Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)

Get 25% off your first bioreagent online order — use code: PROTEOSHOP25

Brand: ProteoGenix

Reslizumab Biosimilar – Anti-IL5 mAb – Research Grade

Clonality:
Monoclonal Antibody
Isotype:
IgG4-nd

200.00

100ug + 200 loyalty points
Size
  • In Stock
  • Free shipping in EU on orders > €500
  • Wide range of unique reagents
  • Fast worldwide delivery

Reslizumab Biosimilar - Anti-IL5 mAb - Research Grade

Product name Reslizumab Biosimilar - Anti-IL5 mAb - Research Grade
Source CAS 241473-69-8
Species Humanized
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Reslizumab,CDP-835,JES1-39D10,SCH55700,IL5,anti-IL5
Reference PX-TA1198
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG4-nd
Clonality Monoclonal Antibody
Product name Reslizumab Biosimilar - Anti-IL5 mAb - Research Grade
Source CAS 241473-69-8
Species Humanized
Expression system Mammalian cells
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Reslizumab,CDP-835,JES1-39D10,SCH55700,IL5,anti-IL5
Reference PX-TA1198
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG4-nd
Clonality Monoclonal Antibody

General information on Anti-IL5(Homo sapiens) (Reslizumab) Monoclonal Antibody

Reslizumab is a humanized interleukin 5 (IL-5) antagonist monoclonal antibody (IgG4 kappa), produced by recombinant DNA technology in murine non-secretory myeloma 0 (NS0) cells. IL-5 is a pro-inflammatory cytokine responsible for the growth and differentiation, recruitment, activation and survival of eosinophil markers. Elevated levels of eosinophils increase the risk of exacerbation of asthma, including allergic and non-allergic forms of asthma characterized by eosinophilia. By targeting IL-5 and disrupting its signaling pathway, reslizumab aims to inhibit the maturation of eosinophils and promote programmed cell death. Reslizumab is sold as Cinqaero in Europe.

There are no reviews yet.

Be the first to review “Reslizumab Biosimilar – Anti-IL5 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products